256 related articles for article (PubMed ID: 20505281)
1. Effects of cevimeline on the immunolocalization of aquaporin-5 and the ultrastructure of salivary glands in Sjögren's syndrome model mice.
Nishimura H; Yakeishi A; Saga T; Yamaki K
Kurume Med J; 2009; 56(3-4):39-47. PubMed ID: 20505281
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemistry-based study on aquaporin (AQP)-1, 3, 4, 5 and 8 in the parotid glands, submandibular glands and sublingual glands of Sjögren's syndrome mouse models chronically administered cevimeline.
Nakamura M; Saga T; Watanabe K; Takahashi N; Tabira Y; Kusukawa J; Yamaki K
Kurume Med J; 2013; 60(1):7-19. PubMed ID: 23925155
[TBL] [Abstract][Full Text] [Related]
3. Effects of total glucosides of peony on AQP-5 and its mRNA expression in submandibular glands of NOD mice with Sjogren's syndrome.
Wu GL; Pu XH; Yu GY; Li TY
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):173-8. PubMed ID: 25635992
[TBL] [Abstract][Full Text] [Related]
4. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
Fox RI; Konttinen Y; Fisher A
Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of cAMP-PKA Signaling Pathway Mediated by Shaoyao Gancao Decoction () on Regulation of Aquaporin 5 and Muscarinic Receptor 3 Levels in Sjögren's Syndrome.
Wang D; Zhao H; Li B; Sun Y; Wei DH
Chin J Integr Med; 2020 Jul; 26(7):502-509. PubMed ID: 32632716
[TBL] [Abstract][Full Text] [Related]
6. Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.
Soyfoo MS; De Vriese C; Debaix H; Martin-Martinez MD; Mathieu C; Devuyst O; Steinfeld SD; Delporte C
Arthritis Rheum; 2007 Aug; 56(8):2566-74. PubMed ID: 17665453
[TBL] [Abstract][Full Text] [Related]
7. [Cevimeline hydrochloride hydrate (Saligren capsule 30 mg): a review of its pharmacological profiles and clinical potential in xerostomia].
Shiozawa A
Nihon Yakurigaku Zasshi; 2002 Oct; 120(4):253-8. PubMed ID: 12425151
[TBL] [Abstract][Full Text] [Related]
8. Efficacy prediction of cevimeline in patients with Sjögren's syndrome.
Yamada H; Nakagawa Y; Wakamatsu E; Sumida T; Yamachika S; Nomura Y; Mishima K; Saito I
Clin Rheumatol; 2007 Aug; 26(8):1320-7. PubMed ID: 17221146
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
Ogawa N; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Wano Y; Hirose Y; Sugai S
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K
Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277
[TBL] [Abstract][Full Text] [Related]
11. Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren's syndrome.
Xiao L; Ng TB; Feng YB; Yao T; Wong JH; Yao RM; Li L; Mo FZ; Xiao Y; Shaw PC; Li ZM; Sze SC; Zhang KY
Phytomedicine; 2011 Jan; 18(2-3):194-8. PubMed ID: 20655712
[TBL] [Abstract][Full Text] [Related]
12. Effect of cevimeline on radiation-induced salivary gland dysfunction and AQP5 in submandibular gland in mice.
Takakura K; Takaki S; Takeda I; Hanaue N; Kizu Y; Tonogi M; Yamane GY
Bull Tokyo Dent Coll; 2007 May; 48(2):47-56. PubMed ID: 17978545
[TBL] [Abstract][Full Text] [Related]
13. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of AQP-5 in rat parotid and submandibular salivary glands after stimulation or inhibition of secretion in vivo.
Gresz V; Kwon TH; Gong H; Agre P; Steward MC; King LS; Nielsen S
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G151-61. PubMed ID: 14988067
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S
Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244
[TBL] [Abstract][Full Text] [Related]
16. [The effectiveness of cevimeline hydrochloride on dry cough in Sjögren's syndrome].
Nishinarita M; Hanzawa M; Iikuni N; Ota S
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):99-102. PubMed ID: 15164930
[TBL] [Abstract][Full Text] [Related]
17. Cevimeline.
Weber J; Keating GM
Drugs; 2008; 68(12):1691-8. PubMed ID: 18681491
[TBL] [Abstract][Full Text] [Related]
18. Correlation between salivary secretion and salivary AQP5 levels in health and disease.
Wang D; Iwata F; Muraguchi M; Ooga K; Ohmoto Y; Takai M; Mori T; Ishikawa Y
J Med Invest; 2009; 56 Suppl():350-3. PubMed ID: 20224222
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB.
Saito K; Mori S; Date F; Hong G
Autoimmunity; 2015; 48(6):379-88. PubMed ID: 25847253
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis on pharmacological therapies in the management of xerostomia in patients with Sjogren's syndrome.
Garlapati K; Kammari A; Badam RK; B E S; Boringi M; Soni P
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):312-318. PubMed ID: 30932714
[No Abstract] [Full Text] [Related]
[Next] [New Search]